Company
BlueWillow Biologics
Realizing the promise of intranasal vaccines
Also known as BlueWillow Biologics, Inc.
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Headquarters
- Ann Arbor, MI, United States
- Legal name
- BlueWillow Biologics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
BlueWillow Biologics® is a clinical-stage biotechnology company pioneering the future of intranasal vaccines.
Funding snapshot
- Total raised
- $35MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $850K2024-01-30
Funding rounds
- Round, 2024
- $850K2024-01-30, SEC form D sold, 2 investors
- Round, 2022
- $5.9M2022-09-19, SEC form D sold, 16 investors
- Round, 2020
- $8.2M2020-03-31, SEC form D sold, 19 investors
- Round, 2019
- $800K2019-08-28, SEC form D sold, 4 investors
- Round, 2018
- $6.7M2018-02-16, SEC form D sold, 17 investors
- Round, 2017
- $775K2017-01-31, SEC form D sold, 5 investors
- Round, 2015
- $1.8M2015-12-22, SEC form D sold, 6 investors
- Round, 2008
- $10M2008-08-23, SEC form D sold, 3 investors
Loading relationship preview